VR17-04 - CAS 2417925-64-3

VR17-04, a metabolite of Enisamium, inhibits the incorporation of GTP and UTP during RNA synthesis. Its mechanism of action was elucidated through docking and molecular dynamics simulations. These findings suggest that VR17-04 could serve as a potential antiviral strategy for managing COVID-19.

2417858

C14H15N2O2

243.28

O=C(NCC=1C=CC=CC1)C2=CC=[N+](C=C2O)C

-20°C

Ice Packs

Small Compound